Roy Mano retweeted
טיפולים מתקדמים ב #סרטןהערמונית כולל ניתוחים רובוטיים, טיפולים פוקאלים, קרינה מבוססת MRI, טיפולים מכווני מטרה נדונו הערב בכנס ארצי למטופלים (מעל 600 נרשמים) בשיתוף עמותת חיים עם סרטן הערמונית. תודה לקולגות @RoyManoMD @sarid_david
חגי ליגומסקי עופר יוספןביץ יסמין נתן עוז
Roy Mano retweeted
תודה ל-400 מטופלים ובני משפחות מכל רחבי הארץ שנרשמו היום בובינר בנושא #גידול #שלפוחיתהשתן. ולמרצים
@sarid_david
@RoyManoMD
@yossepowitch_MD
, Hagai Ligumsky MD
@Yasmin Natan Oz
תודה ל @yaelbiegun המדהימה על הארגון
@cancer_org_il
webclass.co.il/meeting/bladd…
Roy Mano retweeted
Thanks to
> 600 registered patients / families who participated in a national evening during
#prostatecancer awareness month
the Association for Life with Prostate Cancer
colleagues
@RoyManoMD, Ofer Yossepowitch @sarid_david, Dr Yasmin Natan Oz
@tasmc1
@cancer_org_il
Roy Mano retweeted
Roy Mano retweeted
How can guidelines give clearer guidance? In our view, guideline groups must come together to agree on a framework that produces clear and unified recommendations on prostate cancer screening. @WilliamOhMD @JAMAOnc @UrologyMSK jamanetwork.com/journals/jam…
Roy Mano retweeted
Thanks to 400 of patients and family members from all over the country who subscribed to #bladdercancer webinar this evening.
Thanks to great colleagues from @tasmc1 including @RoyManoMD
@OferYossepowitch, @yasminNatan-Oz, @sarid_david, and @NiritRotem Lehrer
Roy Mano retweeted
Enjoy our recent study about the predictive value of pelvic drain after RARP for diagnosing urinary leak: doi.org/10.1111/1744-1633.12…. @Eugenio_Bologna @RoyManoMD @ybaryosef @KarinLifshitz @SDekalo @yossepowitch_MD – at Israel
Roy Mano retweeted
Are some of these patients candidates for RARC+UCS?
@HaimHerzberg and @RoyManoMD just published their excellent work in UO about the natural history of non-curative treatment for MIBC. Reporting 65% of the patients suffered from recurrent hematuria and 37% carried a nephrostomy tube with median emergency visits of 4. Notably, 77% of the cohort were ASA 2 or 3!
sciencedirect.com/science/ar…
Robotic radical cystectomy with cutaneous ureterostomies is a rarely used urinary diversion. Selected patients with limited life expectancy or competing co-morbidities may benefit from its shorter operative times and potentially lower complication rates by avoiding enteric anastomosis.
On the path of expanding our surgical armamentarium further.
@DrJohnSfakianos @MehrazinMD @AlbertoMartini_ @NDTillu
link.springer.com/article/10…
Roy Mano retweeted
Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer buff.ly/3UrXJAk
Roy Mano retweeted
Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm. G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’
Roy Mano retweeted
Now published in @JUrology by @UrologyMSK @vinlaudonemd @SaveYourSexLife et al.:
Do phosphodiesterase type 5 inhibitors increase the risk of biochemical recurrence after radical prostatectomy?
auajournals.org/doi/10.1097/…
Roy Mano retweeted
Our prospective study about psychological features and post-RARP urinary incontinence. The tendency to believe in personal control over actions and outcomes is associated with less incontinence. Should psycho-therapy be part of the urinary rehabilitation??
jomh.org/articles/10.22514/j… – at Israel
Roy Mano retweeted
Performance of standard systematic biopsy versus MRI/TRUS fusion biopsy using the Navigo® system in contemporary cohort buff.ly/3IjYDrp
canjurol.com/abstract.php?Ar…
Recent publication from our group at @SouraskyMedCtr. Patients with a PI-RADS 3 lesion and PSAD≤0.15 had a 4% risk of clinically significant prostate cancer and did not show an association between biopsy delay time and the finding of significant cancer.
Roy Mano retweeted
Frail patients have poorer survival outcomes after cystectomy. The modified frailty index (mFI) may assist to select patients: Our Israeli multi-center study from IUOC. @RoyManoMD @ShayGo15 @IUOC3 @yossepowitch_MD
geriatriconcology.net/articl… – at Israel
Roy Mano retweeted
Now published in @JGeriOnc a collaboration by @UrologyTLVMC @ZivSavin @RoyManoMD @shaygo1 @IUOC3 et al. 11-item modified frailty index and outcomes after radical cystectomy.
geriatriconcology.net/articl…
Roy Mano retweeted
Our multicenter study is online: MUST score may serve as a prognostic predictor for patients undergoing radical cystectomy. We thank all the participating centers and hope for more collaborations.
authors.elsevier.com/a/1hCyJ…
@UrologyTLVMC @SouraskyMedCtr @IUOC3 @RoyManoMD @shaygo1 – at Israel
Roy Mano retweeted
Tandem ureteral stents are commonly used to drain malignant ureteral obstruction. With the following article we tried to identify those patients who will benefit the most from this type of drainage.
@tandfonline @RoyManoMD @SavinZiv @mario_sofer @ybaryosef tandfonline.com/doi/full/10.… – at Israel






















